SUMMARY
Objective To estimate the 2020 all-cause and COVID-19 excess mortality according to sex, age, race/color, and state, and to compare mortality rates by selected causes with that of the five previous years in Brazil.
Methods Data from the Mortality Information System were used. Expected deaths for 2020 were estimated from 2015 to 2019 data using a negative binomial log-linear model.
Results Excess deaths in Brazil in 2020 amounted to 13.7%, and the ratio of excess deaths to COVID-19 deaths was 0.90. Reductions in deaths from cardiovascular diseases (CVD), respiratory diseases, and external causes, and an increase in ill-defined causes were all noted. Excess deaths were also found to be heterogeneous, being higher in the Northern, Center-Western, and Northeastern states. In some states, the number of COVID-19 deaths was lower than that of excess deaths, whereas the opposite occurred in others. Moreover, excess deaths were higher in men, in those aged 20 to 59, and in black, yellow, or indigenous individuals. Meanwhile, excess mortality was lower in women, individuals aged 80 years or older, and in whites. Additionally, deaths among those aged 0 to 19 were 7.2% lower than expected, with reduction in mortality from respiratory diseases and external causes. There was also a drop in mortality due to external causes in men and in those aged 20 to 39 years. Furthermore, reductions in deaths from CVD and neoplasms were noted in some states and groups.
Conclusion There is evidence of underreporting of COVID-19 deaths and of the possible impact of restrictive measures in the reduction of deaths from external causes and respiratory diseases. The impacts of COVID-19 on mortality were heterogeneous among the states and groups, revealing that regional, demographic, socioeconomic, and racial differences expose individuals in distinct ways to the risk of death from both COVID-19 and other causes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funded by the call MCTIC/CNPq/FNDCT/MS/SCTIE/Decit No. 07/2020 - Research to address COVID-19, its consequences and other severe acute respiratory syndromes. Grant term: 401734/2020-0. Funded by FAPEMA n.06/2020 - Support for research on facing the COVID-19 pandemic and post-pandemic. Grant term: 003299/2020.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Since the present study used public and unidentified secondary data, approval from the Ethics Committee on Research in Human Beings was waived (Resolution no. 510/2016 of the National Health Council).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding:Funded by the call MCTIC/CNPq/FNDCT/MS/SCTIE/Decit No. 07/2020 - Research to address COVID-19, its consequences and other severe acute respiratory syndromes. Grant term: 401734/2020-0.
Funded by FAPEMA n.06/2020 - Support for research on facing the COVID-19 pandemic and post-pandemic. Grant term: 003299/2020.
Data Availability
The R scripts for all analyses performed in this study can be accessed at the author's github. Records regarding non-fetal deaths from the years 2015 to 2020 were obtained from the national Mortality Information System (SIM) available at the website opendatasus.saude.gov.br Demographic/population data were obtained from the Brazilian Institute of Geographics and Statistics (IBGE).